home / stock / syggf / syggf quote
Last: | $0.0565 |
---|---|
Change Percent: | 0.0% |
Open: | $0.0565 |
Close: | $0.0565 |
High: | $0.0565 |
Low: | $0.0565 |
Volume: | 2,000 |
Last Trade Date Time: | 07/09/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.0565 | $0.0565 | $0.0565 | $0.0565 | $0.0565 | 2,000 | 07-09-2024 |
$0.05 | $0.05 | $0.05 | $0.05 | $0.05 | 4,000 | 07-05-2024 |
$0.055 | $0.0574 | $0.055 | $0.0574 | $0.055 | 1,200 | 06-26-2024 |
$0.0672 | $0 | $0.0672 | $0 | $0 | 50 | 06-21-2024 |
$0.0672 | $0 | $0.0672 | $0 | $0 | 15 | 06-18-2024 |
$0.0672 | $0.0672 | $0.0672 | $0.0672 | $0.0672 | 4,500 | 06-14-2024 |
$0.063 | $0.063 | $0.063 | $0.063 | $0.063 | 10,000 | 06-13-2024 |
$0.06605 | $0.06605 | $0.06605 | $0.06605 | $0.06605 | 3,000 | 06-11-2024 |
$0.07265 | $0 | $0.07265 | $0 | $0 | 5 | 06-10-2024 |
$0.07265 | $0.07265 | $0.07265 | $0.07265 | $0.07265 | 800 | 06-07-2024 |
$0.069 | $0.069 | $0.069 | $0.069 | $0.069 | 100 | 06-06-2024 |
$0.08296 | $0.08296 | $0.08296 | $0.08296 | $0.08296 | 1,000 | 05-29-2024 |
$0.0652 | $0.0652 | $0.0652 | $0.0652 | $0.0652 | 666 | 05-28-2024 |
$0.08775 | $0.08775 | $0.08775 | $0.08775 | $0.08775 | 100 | 05-21-2024 |
$0.09 | $0.09 | $0.09 | $0.09 | $0.09 | 100 | 05-20-2024 |
$0.07508 | $0.07508 | $0.07508 | $0.07508 | $0.07508 | 500 | 05-15-2024 |
$0.066 | $0.0639 | $0.066 | $0.066 | $0.0639 | 1,350 | 05-06-2024 |
$0.0558 | $0 | $0.0558 | $0 | $0 | 80 | 04-23-2024 |
$0.0558 | $0.0558 | $0.0558 | $0.0558 | $0.0558 | 1,000 | 04-19-2024 |
$0.0505 | $0.07425 | $0.0505 | $0.07425 | $0.0505 | 5,000 | 04-11-2024 |
News, Short Squeeze, Breakout and More Instantly...
(NewsDirect) Synairgen PLC (AIM:SNG, OTC:SYGGF) chief executive Richard Marsden speaks to Thomas Warner from Proactive London about the company's ongoing efforts to develop what he describes as a "drug to help patients handle respiratory viruses." He explains that work on the drug lon...
(NewsDirect) Synairgen PLC (AIM:SNG, OTC:SYGGF) chief executive Richard Marsden talks to Proactive following the release of full year results for calendar year 2022 - a year he says was "quite challenging at times." Marsden discusses the UK-based respiratory company's clinical development...